Answers are grounded in this paper and cite their sources.
Parkinson's disease (PD) is a neurodegenerative disorder that affects many people. While a variety of non-motor manifestations may occur, the typical clinical characteristics include a mobility disorder characterized by dyskinesia, resting tremor, and rigidity, with spasticity developing later. The cause of Parkinson's disease is unknown, but several genetic risk factors and several genes that cause rare familial forms of the disease have now been identified. Environmental factors such as tobacco smoke, coffee intake, and exposure to toxic substances have been proposed to alter the risk of Parkinson's disease development, while their function remains unknown. The movement problem is caused by the death of dopaminergic neurons in the substantia nigra pars compacta, with intracellular aggregation of -synuclein in the form of Lewy bodies and Lewy neurites being the pathogenic hallmark. Sleep difficulties are widespread in Parkinson's disease (PD), as reported by nearly two-thirds of PD patients. They are characterized clinically as disorders of the beginning and continuation of sleep, hypnagogic hallucinations, and severe daytime drowsiness SDD. DIMS is caused by degenerative changes in the CNS that affect sleep regulation centers, the persistence of daytime PDrelated symptoms into the night, concurrent mental health disease, instability of circadian rhythms, and the effects of signal transduction pathways (and other) medication on circadian rhythm. This review gives detailed information about the manifestations and clinical approaches in treating PD and also focuses on the preferential signs and symptoms associated with the incurring stage of the disease.
No takes yet. Share an insight, caveat, or question.
Dwivedi et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: